RxDoctor Payments Data

Earl Draves, MD

Family Medicine · Festus, MONPI 1164416624

Payments from drug & device makers

$1,325in general payments, 2019–2025

Across 67 payments — averaging $19.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Astellas Pharma US Inc$20
  • GSK$20
  • Boehringer Ingelheim$16

What the payments were for

  • Food & beverage$1,325100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)64$1,270
Astellas Pharma US Inc1$20
GSK1$20
Boehringer Ingelheim1$16

How this compares

$1,325 in reported general payments places this provider in the 65th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$194,019
Medicare patients
508
Services billed
2,758

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban272$284,131
OzempicSemaglutide159$218,688
JanuviaSitagliptin Phosphate73$88,622
JardianceEmpagliflozin63$81,760
XareltoRivaroxaban91$75,320
MounjaroTirzepatide46$59,497
CreonLipase/Protease/Amylase18$49,613
TrulicityDulaglutide17$42,721
Breo ElliptaFluticasone/Vilanterol64$28,175
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$26,670
LinzessLinaclotide21$23,310
TradjentaLinagliptin24$17,642
MyrbetriqMirabegron28$17,038
Lantus SolostarInsulin Glargine,hum.Rec.Anlog77$16,254
Atorvastatin Calcium1,651$16,075

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat$16$108,743103 claims
AbbVieCreon, Linzess$1,270$72,92339 claims
GSKBreo Ellipta, Trelegy Ellipta, Arexvy$20$68,957135 claims
Astellas Pharma US IncMyrbetriq$20$17,03828 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Festus

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →